Table 1.

Patient Characteristics

Characteristic TPO Study Group (n = 26) Control Group (n = 20)
Median Range Median Range
Age (yr)  44  33-60 48  27-60  
No. of prior chemotherapy  regimens  1 1-4  1  1-3  
No. of prior chemotherapy  cycles  6 3-23  6  1-18  
Days from apheresis to  reinfusion  30  29-45  30.5  23-44 
 No.% No.%  
Stage II/III disease  16 62  12  60  
Stage IV  10  38 8  40  
Prior radiation  4  15  6 30 
Characteristic TPO Study Group (n = 26) Control Group (n = 20)
Median Range Median Range
Age (yr)  44  33-60 48  27-60  
No. of prior chemotherapy  regimens  1 1-4  1  1-3  
No. of prior chemotherapy  cycles  6 3-23  6  1-18  
Days from apheresis to  reinfusion  30  29-45  30.5  23-44 
 No.% No.%  
Stage II/III disease  16 62  12  60  
Stage IV  10  38 8  40  
Prior radiation  4  15  6 30 
View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal